Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Sacituzumab Govitecan-hziy in Metastatic Urothelial Cancer (TROPHY U-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03547973
Recruitment Status : Recruiting
First Posted : June 6, 2018
Last Update Posted : July 25, 2022
Information provided by (Responsible Party):
Gilead Sciences